US Patent 10143187 Transferrin receptor transgenic models
Patent 10143187 was granted and assigned to Denali Therapeutics on December, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+316 characters)
Article
Patent abstract
In some aspects, the present invention provides chimeric transferrin receptor (TfR) polynucleotides and polypeptides. In other aspects, this invention provides chimeric TfR transgenic animal models and methods of using the animal models to identify therapeutics that can cross the blood-brain barrier.
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101431870
Date of Patent
December 4, 2018
0Patent Application Number
159239280
Date Filed
March 16, 2018
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101431870
Date of Patent
December 4, 2018
0Patent Application Number
159239280
Date Filed
March 16, 2018
0Patent Primary Examiner
Edits on 23 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10143187 Transferrin receptor transgenic models
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10143187
Date of patent
December 4, 2018
Patent application number
15923928
Date Filed
March 16, 2018
Patent primary examiner
Find more entities like US Patent 10143187 Transferrin receptor transgenic models
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
